79219 Staufen, de
+41 (61) 4856-560
Bilcare Research Announces Investment in US production of Aclar® laminates
Part of the global Pharmaceutical Packaging Innovation (PPI) Business Unit of Bilcare Research AG, Bilcare Research offers a variety of mono and barrier blister films to the pharmaceutical packaging industry. In addition to manufacturing pharmaceutical blister films, the company also produces products for other business units of the company.
“This investment in a new laminating line is just the latest component of our continued growth strategy to meet the needs of the rapidly evolving business models of the global pharmaceutical industry. We see increased demand across our entire range of Bilcare Aclar® laminates, from both, ethical and generic pharmaceutical companies,” said Kevin Stevens, President and Managing Director of Bilcare Research Inc. “The lamination line is a further execution of Bilcare’s strategic investment of €50 Million and is a natural progression to the industry-specific segregation project for our PPI production. The new capacity will be fully available beginning of 2017.”
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.